WILMINGTON – BioSpecifics Technologies Corp. announced Monday morning that it has entered into a merger deal with pharmaceutical giant Endo International PLC worth $540 million. As a small commercial-stage biopharmaceutical […]
NEW YORK – It will come as no great surprise that Delaware-based financial and chemical companies had a rough first quarter – particularly in March – thanks to the coronavirus […]
Incyte, the Delaware-based pharmaceutical research firm, has joined the S&P 500 Index. The index includes the most-owned stocks on the New York Stock Exchange and Nasdaq, the two largest exchanges […]
Somsak Chivavibul, CFO for Wilmington-based Navient, will join leaders from more than 20 companies in ringing the opening bell at Nasdaq this Friday to celebrate Veterans Day. The opening bell […]
© 2023 Delaware Business Times